CD4 and neoplasm: When examining the role of T-cells in these observations, HDACi was shown to drive trafficking of T-cells to tumours, potentiating the anti-tumour response through CD4+ and CD8+ effector T-cells, whilst decreasing the presence of immunosuppressive immature myeloid cells [101].